Department of Physiotherapy, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, # Damavand Ave, Zip code:16169-13111, Tehran, Iran.
Department of Physiotherapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.
Chiropr Man Therap. 2021 Sep 27;29(1):40. doi: 10.1186/s12998-021-00396-z.
Myofascial pain syndrome (MPS) is one of the most common disorders causing chronic muscle pain. Almost one-third of patients with musculoskeletal complaints meet the MPS criteria. The aim of this study is to evaluate the effectiveness of intramuscular electrical stimulation (IMES) in patients with MPS through a systematic review method.
PubMed, Scopus, Embase, ProQuest, PEDro, Web of Science, and CINAHL were systematically searched to find out the eligible articles without language limitations from 1990 to December 30, 2020. All relevant randomized controlled trials that compared the effectiveness of IMES with sham-IMES, dry needling, or exercise therapy in patients with MPS were included. Full texts of the selected studies were critically appraised using Revised Cochrane risk-of-bias tool for randomized trials (RoB2).
Six studies (out of 397) had met our inclusion criteria (involving 158 patients) and were entered to the systematic review. Outcome measures examined in these studies included pain, range of motion, pressure pain threshold, biochemical factors, disability, and amount of analgesic use. In the most studies, it has been shown that IMES is more effective than the control group in improving some outcome measurements such as pain.
There is preliminary evidence from a few small trials suggesting the efficacy of IMES for the care of myofascial pain syndrome. The data support the conduct of larger trials investigating the efficacy of IMES.
肌筋膜疼痛综合征(MPS)是导致慢性肌肉疼痛的最常见疾病之一。几乎有三分之一的肌肉骨骼投诉患者符合 MPS 标准。本研究旨在通过系统评价方法评估肌内电刺激(IMES)在 MPS 患者中的疗效。
从 1990 年 1 月至 2020 年 12 月 30 日,系统检索了 PubMed、Scopus、Embase、ProQuest、PEDro、Web of Science 和 CINAHL,以查找无语言限制的合格文章。纳入了所有比较 IMES 与假 IMES、干针、或运动疗法对 MPS 患者有效性的相关随机对照试验。使用修订后的 Cochrane 随机试验偏倚风险工具(RoB2)对入选研究的全文进行严格评价。
有 6 项研究(397 项中的 6 项)符合纳入标准(涉及 158 名患者),并纳入系统评价。这些研究中检查的结局指标包括疼痛、运动范围、压痛阈值、生化因素、残疾和镇痛药使用量。在大多数研究中,IMES 在改善疼痛等一些结局测量方面比对照组更有效。
少数小型试验初步证据表明 IMES 对肌筋膜疼痛综合征的疗效。这些数据支持进行更大规模的试验来研究 IMES 的疗效。